tiprankstipranks
Zenas BioPharma price target lowered to $35 from $40 at Morgan Stanley
PremiumThe FlyZenas BioPharma price target lowered to $35 from $40 at Morgan Stanley
3M ago
Zenas BioPharma reports Q3 EPS ($5.02), consensus ($9.33)
Premium
The Fly
Zenas BioPharma reports Q3 EPS ($5.02), consensus ($9.33)
4M ago
Zenas BioPharma completed targeted enrollment of Phase 3 INDIGO trial
Premium
The Fly
Zenas BioPharma completed targeted enrollment of Phase 3 INDIGO trial
4M ago
Zenas BioPharma initiated with a Buy at Guggenheim
PremiumThe FlyZenas BioPharma initiated with a Buy at Guggenheim
5M ago
Zenas BioPharma initiated with an Overweight at Morgan Stanley
Premium
The Fly
Zenas BioPharma initiated with an Overweight at Morgan Stanley
5M ago
Opening Day: StandardAero surges in market debut
Premium
The Fly
Opening Day: StandardAero surges in market debut
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100